CA2558659A1 - Lignee de vaccins basee sur le virus de la variole du canari genetiquement modifie - Google Patents

Lignee de vaccins basee sur le virus de la variole du canari genetiquement modifie Download PDF

Info

Publication number
CA2558659A1
CA2558659A1 CA002558659A CA2558659A CA2558659A1 CA 2558659 A1 CA2558659 A1 CA 2558659A1 CA 002558659 A CA002558659 A CA 002558659A CA 2558659 A CA2558659 A CA 2558659A CA 2558659 A1 CA2558659 A1 CA 2558659A1
Authority
CA
Canada
Prior art keywords
virus
inactivated
recombinant
genetic functions
poxvirus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002558659A
Other languages
English (en)
Other versions
CA2558659C (fr
Inventor
Enzo Paoletti
Marion E. Perkus
Jill Taylor
James Tartaglia
Elizabeth K. Norton
Michel Riviere
Charles De Taisne
Keith J. Limbach
Gerard P. Johnson
Steven E. Pincus
William I. Cox
Jean-Christophe F. Audonnet
Russell Robert Gettig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Connaught Technology Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA2621088A priority Critical patent/CA2621088C/fr
Priority claimed from CA002105277A external-priority patent/CA2105277C/fr
Publication of CA2558659A1 publication Critical patent/CA2558659A1/fr
Application granted granted Critical
Publication of CA2558659C publication Critical patent/CA2558659C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA002558659A 1991-03-07 1992-03-09 Lignee de vaccins basee sur le virus de la variole du canari genetiquement modifie Expired - Lifetime CA2558659C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA2621088A CA2621088C (fr) 1991-03-07 1992-03-09 Souche vaccinale a base de variole aviaire a manipulation genetique

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US66605691A 1991-03-07 1991-03-07
US666,056 1991-03-07
US71396791A 1991-06-11 1991-06-11
US713,967 1991-06-11
US84795192A 1992-03-06 1992-03-06
US847,951 1992-03-06
CA002105277A CA2105277C (fr) 1991-03-07 1992-03-09 Souche de virus de la vaccine genetiquement modifiee

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002105277A Division CA2105277C (fr) 1991-03-07 1992-03-09 Souche de virus de la vaccine genetiquement modifiee

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA2621088A Division CA2621088C (fr) 1991-03-07 1992-03-09 Souche vaccinale a base de variole aviaire a manipulation genetique

Publications (2)

Publication Number Publication Date
CA2558659A1 true CA2558659A1 (fr) 1992-09-17
CA2558659C CA2558659C (fr) 2008-06-03

Family

ID=37310264

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002558659A Expired - Lifetime CA2558659C (fr) 1991-03-07 1992-03-09 Lignee de vaccins basee sur le virus de la variole du canari genetiquement modifie

Country Status (1)

Country Link
CA (1) CA2558659C (fr)

Also Published As

Publication number Publication date
CA2558659C (fr) 2008-06-03

Similar Documents

Publication Publication Date Title
AU1001297A (en) ALVAC canarypox virus recombinants comprising heterologous inserts
OA09777A (en) "Viral defective vaccine produced by transcomplementing cell line"
NO933260L (no) Rekombinante virusvektorer kodende for humane papillomavirus proteiner
CA2031164A1 (fr) Herpesvirus recombinant de dindons et vaccins de vecteur vivant qui en sont derives
AU6564596A (en) Recombinant Attenuated TROVAC Fowlpox Vectors Containing Heterologous DNA Segments Encoding Lentiviral Gene Products
EP0261940A3 (fr) Vaccins pseudorabiques et vecteurs d'ADN pour recombiner avec les poxvirus
CA2105277A1 (fr) Souche de virus de la vaccine genetiquement modifiee
ATE147782T1 (de) Primaten-lentivirus impfstoffe
WO1994013812A3 (fr) Nouveaux genes de l'entomopoxvirus, nouvelles proteines et leurs procedes d'utilisation
DK0586076T3 (da) Rekombinant adenovirus-vacciner
CA2558659A1 (fr) Lignee de vaccins basee sur le virus de la variole du canari genetiquement modifie
CA2116355A1 (fr) Mutants infectieux du virus de la rhinotracheite bovine et vaccins
DE69920192D1 (de) Rekombinantes virus
DE69332678D1 (en) Synthetische promotoren von herpes simplex virus
WO1992014818A3 (fr) Systeme d'expression d'entomopoxvirus comprenant des sequences de spheroïdine ou de thymidine-kinase
ES2074965A1 (es) Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen.
Enzo et al. Genetically engineered vaccine strain
BRATISLAVA EXPERIMENTAL INFECTION OF ORGAN CULTURES OF PANCREAS OF WHITE SUCKLING MICE BY TICK ENCEPHALITIS VIRUS AND SINDBIS VIRUS
WO2002078621A3 (fr) Virus de recombinaison capable de replication et procedes d'utilisation de celui-ci

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry